Question 1

Does Citigroup own AKBA stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Citigroup holds 1,124,570 shares of AKBA (Akebia Therapeutics), worth $1.3M.

Question 2

How many shares of AKBA does Citigroup own?

Accepted Answer

As of its Q2 2026 13F, Citigroup holds 1,124,570 shares of AKBA (Akebia Therapeutics).

Question 3

What is Citigroup's AKBA position worth?

Accepted Answer

As of its Q2 2026 13F, Citigroup's AKBA position is worth $1.3M.

Question 4

Is Citigroup buying or selling AKBA?

Accepted Answer

In Q2 2026, Citigroup reduced its AKBA position by 1,730,016 shares (-60.6%).

Question 5

When did Citigroup first buy AKBA?

Accepted Answer

Citigroup already held AKBA in its Q4 2023 13F, the earliest on record, and has listed it in 11 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	1.1M	-60.6%	$1.3M	0.0%	$1.14	0
2026-Q1	Increased	2.9M	+17.2%	$4M	0.0%	$1.22	31
2025-Q4	Increased	2.4M	+27.1%	$3.9M	0.0%	$1.59	33
2025-Q3	Increased	1.9M	+1324.7%	$5.2M	0.0%	$2.71	44
2025-Q2	Decreased	134,530	-56.0%	$489,689	0.0%	$3.65	0
2025-Q1	Increased	306,000	+29.2%	$587,520	0.0%	$1.91	31
2024-Q4	Increased	236,786	+56.4%	$449,894	0.0%	$1.85	34
2024-Q3	Increased	151,405	+225.2%	$199,855	0.0%	$1.33	37

AKBAShowing 8 of 11 quarters

AKBA
Showing 8 of 11 quarters